Nucynta ER 150 mg/1 (Tapentadol Hydrochloride TABLET, FILM COATED, EXTENDED RELEASE) 150 mg/1

Nucynta ER 150 mg is an extended-release tablet containing tapentadol hydrochloride, used for managing moderate to severe pain. This medication is designed to provide long-lasting relief, making it suitable for around-the-clock pain management.

Strength

150 mg/1

Pack Size

60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24510-174-60)

Manufacturer / TM Owner

Collegium Pharmaceutical, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nucynta ER 150 mg is primarily used for the management of moderate to severe chronic pain. It is often prescribed for conditions that require extended pain relief, such as neuropathic pain or musculoskeletal pain. The extended-release formulation ensures that the active ingredient, tapentadol hydrochloride, is released slowly over time, providing consistent pain relief throughout the day. Patients often ask, 'What is Nucynta ER used for?' This medication is designed to help those who need continuous pain management.

Side Effects

Common effects of Nucynta ER 150 mg may include dizziness, nausea, and constipation. Some users might experience drowsiness or vomiting. These effects can vary from person to person and may subside as the body adjusts to the medication. It's important to monitor how you feel when starting this medication and consult a healthcare provider if any effects are concerning.

Precautions & Warnings

Nucynta ER 150 mg should be handled with care. It is important to follow the prescribed dosage and not to crush, chew, or break the extended-release tablets, as this can affect the controlled release of the medication. Store the medication in a safe place to prevent misuse. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

Nucynta ER 150 mg may interact with other medications, including those that cause drowsiness or affect the central nervous system. Alcohol should be avoided while taking this medication, as it can enhance the sedative effects. Additionally, certain antidepressants, antipsychotics, and other pain medications may interact with tapentadol hydrochloride. Always consult a healthcare provider before starting any new medication.

Frequently Asked Questions

Nucynta ER is used for managing moderate to severe chronic pain that requires around-the-clock relief.

Nucynta ER should be taken orally, whole, with or without food, as directed by your healthcare provider.

Common side effects may include dizziness, nausea, constipation, and drowsiness.

It is advised to avoid alcohol while taking Nucynta ER, as it can enhance the sedative effects.

Store Nucynta ER in a safe place at room temperature, away from moisture and heat.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.